BXRX
Price:
$0.0218
Market Cap:
$436.00
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
Industry
Biotechnology
IPO Date
2019-11-14
Stock Exchange
NASDAQ
Ticker
BXRX
According to Baudax Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -96.46% compared to the average of -0.01 of the last 4 quarters.
The mean historical PE Ratio of Baudax Bio, Inc. over the last ten years is -0.00. The current -0.00 PE Ratio has changed 68.88% with respect to the historical average. Over the past ten years (40 quarters), BXRX's PE Ratio was at its highest in in the March 2023 quarter at 0.00. The PE Ratio was at its lowest in in the September 2023 quarter at -0.02.
Average
-0.00
Median
-0.00
Minimum
-0.00
Maximum
-0.00
Discovering the peaks and valleys of Baudax Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.48%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -17.08%
Minimum Annual PE Ratio = -0.00
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.00 | 103.70% |
| 2021 | -0.00 | 1.48% |
| 2020 | -0.00 | -14.71% |
| 2019 | -0.00 | 133.08% |
| 2018 | -0.00 | -17.08% |
The current PE Ratio of Baudax Bio, Inc. (BXRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.00
5-year avg
-0.00
10-year avg
-0.00
Baudax Bio, Inc.’s PE Ratio is greater than Impel Pharmaceuticals Inc. (-0.01), greater than InVivo Therapeutics Holdings Corporation (-0.05), less than 9 Meters Biopharma, Inc. (0), greater than Altamira Therapeutics Ltd. (-0.02), greater than Bellicum Pharmaceuticals, Inc. (-0.09), greater than Timber Pharmaceuticals, Inc. (-0.04), less than Infinity Pharmaceuticals, Inc. (-0.00), greater than cbdMD, Inc. (-1.40), greater than CohBar, Inc. (-0.10), greater than Lucy Scientific Discovery Inc. (-0.73),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.01 | $956.00K | |
| -0.05 | $995.92K | |
| 0 | $1.45K | |
| -0.02 | $1.13M | |
| -0.09 | $778.33K | |
| -0.04 | $1.18M | |
| -0.00 | $9.05K | |
| -1.40 | $5.44M | |
| -0.10 | $1.19M | |
| -0.73 | $906.91K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Baudax Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Baudax Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Baudax Bio, Inc.'s PE Ratio?
How is the PE Ratio calculated for Baudax Bio, Inc. (BXRX)?
What is the highest PE Ratio for Baudax Bio, Inc. (BXRX)?
What is the 3-year average PE Ratio for Baudax Bio, Inc. (BXRX)?
What is the 5-year average PE Ratio for Baudax Bio, Inc. (BXRX)?
How does the current PE Ratio for Baudax Bio, Inc. (BXRX) compare to its historical average?